The Executive Committee of the European Association for Clinical Pharmacology and Therapeutics (EACPT) met in London 12-13 October, hosted by the British
Pharmacological Society. The main business of this EC meeting was planning for major pending events and activities. Key items included:
Members of the EACPT Executive Committee
the 12th biennial EACPT congress to be held from 27-29 June 2015 in Madrid
– the EACPT focus meeting in Nijmegen in the Netherlands, 3-5 July 2014 – the key theme is cardiovascular.
– update on the official EACPT journal Clinical Therapeutics (online access is a benefit for individual Associates of the EACPT – see register interest link below)
– interaction with key policy organisations interested in medicines and patient safety, including the European Medicines Agency. EACPT chair Professor Gonzalo Calvo is inaugural co-chair of the Healthcare Professionals Working Party of the
|Parliament buildings and former County Hall|
EACPT biennial congresses provide excellent opportunities to showcase issues of topical international concern to the CPT community, through timely and accessible original research presentations and commentaries to policy-makers, health and industry professionals, health technology providers, patient groups and academia.
Co-organisers Marie Besson and Caroline Samer reported on the recent Geneva EACPT Congress. Almost 600 delegates attended the 11th EACPT Congress in Geneva in August 2013, where there were 101 invited speakers from 21 countries – 15 countries from the European region and a further 6 countries internationally, from the USA, Canada, New Zealand, China, Benin and India. 330 abstracts were presented as oral and poster communications, following submissions from 57 countries from all 5 continents.
Key themes at the Madrid congress will include translational medicine and pharmacogenetics, advances in personalised diagnostics to improve the safety and effectiveness of medicines, updates on new biological approaches to disease, therapeutics of cardiovascular, cancer and inflammatory disease, clinical trial design and regulation, drug safety and toxicology, clinical trial design and governance, health policy and safe prescribing.